InsiderStreet Equity Research

Produced by InsiderStreet.ai from live production data. It is not investment advice, not an offer or solicitation to buy or sell any security, and not a recommendation for any investor. Do not rely on it for any investment decision.

Last Close

$147.31

2026-10-16

Market Cap

$10.5B

Volume

1.0M

52-Wk High

$200.44

52-Wk Low

$128.67

Trailing PE

25.6

P/S

2.53

Gross Margin

66.5%

Net Margin

10.0%

ROE

10%

ROIC

9%

Piotroski

7/9

Altman Z

4.5

1-Yr Return

+13.5%

5-Yr Return

-15.6%

Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wide range of dental professionals, including orthodontists, general dentists, and those specializing in restorative and cosmetic dentistry. The company's operations are divided into two main business units: "Clear Aligner" and "Scanners and Services." The Clear Aligner segment offers a variety of solutions. Its comprehensive products include the full Invisalign treatment for teenage patients, designed to address complex orthodontic needs such as mandibular advancement, patient compliance tracking, and managing tooth eruption. It also features specialized Invisalign First Phase I and Phase 2 packages for younger children, typically aged seven to ten, who have mixed dentition (a combination of primary and permanent teeth). Beyond these, the segment provides non-comprehensive aligner options like Invisalign moderate, lite, express, and Invisalign Go. Additional non-case products include retention devices, fees for Invisalign training, and sales of ancillary items such as cleaning materials and adjustment tools used by dental practitioners during treatment. The Scanners and Services segment centers around the iTero scanner, a unified hardware platform offering various software applications for both restorative and orthodontic procedures. It supplies specialized restorative software to general dentists, prosthodontists, periodontists, and oral surgeons, as well as distinct software for orthodontists to manage digital patient records, perform diagnoses, and facilitate the fabrication of printed models and retainers. This segment also provides computer-aided design and manufacturing (CAD/CAM) services, along with supplementary products like disposable covers for the scanner wand and iTero models and dies. Furthermore, it includes third-party scanners and digital scan solutions, the Invisalign Outcome Simulator (a chair-side and cloud-based application for the iTero scanner), the Invisalign Progress Assessment tool, and TimeLapse technology, which enables clinicians to compare a patient's historical 3D scans against current data. Align Technology distributes its products worldwide, with a strong presence in the United States, Switzerland, and China. Founded in 1997, the company is headquartered in Tempe, Arizona.

SectorHealthcareIndustryMedical - DevicesExchangeNASDAQMarket Cap$10.5BEmployees20,290 (SEC-filed)CEOJoseph HoganIPO2001-01-30CountryUS

410 North Scottsdale Road, Tempe, AZ 85288 · Tel 602 742 2000 · aligntech.com

INSIDERSTREET SCORE64 / 100Street mean $185.25 (4 analysts, last qtr) — their number, not ours

INSIDER CONSENSUS SIGNALCOMP-PLAN ACTIVITY ONLYexercises and tax withholding only

1 Year vs S&P 500 · ALGN +13.5% · S&P 500 +15.9% · spread -2.4pp

7 Years vs S&P 500 · ALGN -15.6% · S&P 500 +189.9% · spread -205.4pp

Both charts indexed to 100 at the start of their window and drawn on a single shared scale, so the gap to the benchmark is the gap you see. Adjusted closes throughout.

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

INSIDERSTREET
SCORE64of 100

Score Breakdown

Profitability	49/100
Growth	38/100
Momentum	69/100
Quality	80/100
Earnings Quality	64/100
Balance Sheet	89/100
Value	41/100
Risk (safety)	100/100
Overall	63.7/100

Each component is a diagnostic reading on its own 0-100 scale. The overall score is computed separately from the underlying financials and is not the average of the rows above — components are not equally weighted and three of them (Momentum, Value, Risk) are derived partly from price rather than from the business.

Peer Comparison — IS Score

Symbol	IS Score
GMED	82
PODD	71
GKOS	39
BIO	55
MASI	63
SNN	76
ALGN	64

IS Score Trend — quarterly

14 quarters, 23 Q1 to 26 Q2. Peak 71 in 23 Q4, latest 64 — -7 since. Fell in 2 of the last 4 quarters. Dashed line marks 40 on the 0-100 scale.

BUSINESS QUALITY64 / 100IS Score 63.7 / 100 · -7.3 from peak of 71

Fundamental factor model, quarterly. Measures how the business is doing - not where the price is going.

PRICE STRUCTURELEAN BULLISHTechnical Score 55 / 100 · Power +10 · 14 of 22 indicator votes bullish

Vote share across trend, momentum, volume, volatility and pattern families. Describes where the price is, not where it is going.

Both readings sit above the midpoint — business quality at 64 and price structure at 55 out of 100 — so they are not in conflict. The fundamentals and the tape are saying the same thing, which is the case in which either one alone would have been enough.

Trigger	Where it stands now	What it would mean
IS Score reaches 75 and holds two consecutive quarters	now 63.7	would move us up one band
IS Score stops falling - one quarter higher than the prior	last four: 60 → 62 → 67 → 64	the direction matters more than the level
Technical vote share back above 50%	now 55%	price structure no longer broken
Institutional holder count rises two quarters running	peak 824 → now 678	fewer institutions willing to hold is our clearest warning

We publish these so the view can be shown to be wrong. If none of them move and our reading does, we owe you an explanation.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

This page is InsiderStreet's own reading, produced from the data in the rest of this document. It is not a price target and not investment advice. Analyst consensus and street price targets appear later under their own heading and are the street's numbers, not ours.

Site Convergence Score2 of 4top 13% of 29,420 symbols

Sources Aligned— of 3independent disclosures

Congress (180d)0 buysnone disclosed

Insider Buys (180d)0none disclosed

ETF Funds (30d)522 up / 443 downnet +79 funds

Institutions Added (13F)-13managers opening or increasing

Congressional and insider figures are disclosed purchases in the trailing 180 days; ETF figures are COUNTS OF FUNDS whose holding changed in 30 days, not dollars. Coincidence of separate disclosures, not coordination. An absent source means nothing qualifying was disclosed in its window.

Institutions holding — 12 quarters

Peak 824 · latest 678 (-146 from peak).

Quarter	Holders	13F shares	Value	Reported own%	Guard
2026 Q2	678	73.4M	$12.1B	102.8%	ex-outlier 96.6%
2026 Q1	691	69.4M	$11.8B	97.2%
2025 Q4	666	66.3M	$10.0B	92.8%
2025 Q3	668	69.1M	$8.2B	96.7%
2025 Q2	708	67.4M	$12.4B	94.3%
2025 Q1	693	66.8M	$10.3B	93.5%
2024 Q4	725	65.9M	$13.2B	92.2%
2024 Q3	736	65.7M	$16.0B	92.0%
2024 Q2	771	65.1M	$15.3B	91.0%
2024 Q1	824	65.8M	$21.3B	92.2%
2023 Q4	794	65.0M	$17.6B	91.0%
2023 Q3	812	67.7M	$20.0B	94.7%

How to read ownership above 100%. A 13F reports the positions a manager has investment discretion over, and where two or more managers share discretion over the same block, each one reports it. Summed across filers, the total can therefore exceed the shares actually outstanding without anything being wrong. We publish the figure as filed rather than netting it down, and flag separately any quarter where the arithmetic is not merely high but impossible.

Why 2026-06 reads 102.77%. Institutions cannot hold more of a company than exists. The reported 73.4M shares exceed the 71.5M outstanding, and a single filer accounts for the excess: BlackRock, Inc. reports 4,419,366 shares against 4,289,924 the prior quarter, a 1x jump, which alone would be 6.2% of the company. Excluding that filing, ownership is 96.6%. We publish both figures. 13F filings are due 45 days after quarter end and amendments keep arriving after that, so the newest quarter is provisional by construction - this is what an unsettled quarter looks like.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Insider	Role	Date	Type	Shares	Value	Post-Txn Owned
Blackford Quentin S.	director	2026-08-27	A-Award	1,376	—	1,376
Saia Andrea Lynn	director	2026-05-20	EXERCISE	1,745	—	17,318
Saia Andrea Lynn	director	2026-05-20	EXERCISE	1,745	—	0
Saia Andrea Lynn	director	2026-05-20	A-Award	1,836	—	1,836
Poul Mojdeh	director	2026-05-20	EXERCISE	1,745	—	3,553
Poul Mojdeh	director	2026-05-20	EXERCISE	1,745	—	0
Poul Mojdeh	director	2026-05-20	A-Award	1,836	—	1,836
Myong Anne	director	2026-05-20	EXERCISE	1,745	—	9,830

6-mo decomposition (Form 4)	Txns	Shares	Value	Signal weight
M — Exercises (paired A/D)	10	17,729	—	None — mechanics
P — Open-market purchases	0	0	$0	Counted — none occurred

Monthly Net Insider Flow (000 shares)

Net of acquisitions minus dispositions, all Form 4 types.

Signal Summary

SignalComp-Plan Activity Only

Open-Market Sells$0.0M0 txns / 6 mo

Open-Market Buys$0.0M0 txns / 6 mo

ClusterNone active3+ insiders / 21 days

Filed	Filer	Shares registered	Est. proceeds
2026-02-12	John Morici	7,969	$1.5M
2024-11-25	Wright Emory	2,500	$0.6M
2024-02-29	Joseph S Lacob Tteefbo Joseph S. Lacob Rev Trustu/A/D 07-19-2007	15,000	$4.5M
2024-02-27	Joseph S Lacob Ttee Fbo Joseph S. Lacob Rev Trustu/A/D 07-19-2007	10,000	$3.1M
Trailing 12 mo	1 filings	7,969	$1M

Filed	Form	Reporting person	% of class	Shares
2026-08-12	SCHEDULE 13G/A	Gordon & Llura Gund Foundation	0.40%	0.3M sh
2026-08-12	SCHEDULE 13G/A	Capital World Investors	5.00%	3.6M sh
2026-05-14	SCHEDULE 13G/A	Capital International Investors	5.50%	3.9M sh
2026-05-14	SCHEDULE 13G	Capital World Investors	5.90%	4.2M sh

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Member	Chamber	Trade	Size band	Traded	Disclosed
Ro Khanna	House	SELL	$1,001 - $15,000	2026-09-11	2026-10-09
Ro Khanna	House	SELL	$1,001 - $15,000	2026-09-04	2026-10-09
Ro Khanna	House	SELL	$1,001 - $15,000	2026-01-29	2026-02-10
Dan Sullivan	Senate	SELL	$1,001 - $15,000	2023-08-22	2023-09-22
Dan Sullivan	Senate	SELL	$1,001 - $15,000	2023-08-22	2023-09-21
Daniel Scott Sullivan	Senate	SELL	$1,001 - $15,000	2023-08-22	2023-09-21

House 12-Mo6 trades0 purchases

Senate 12-Mo0 tradesNone purchases

CoverageSTOCK Act filings30-45 day disclosure lag

13F Filers (last complete Q)691

13F Shares69M97.2% of shares out

New / Closed123 / 87positions, QoQ

Increased / Reduced249 / 212positions, QoQ

Put/Call (13F)1.12option positions

Free Float94.1%67M sh

2.8 · Largest Reporting 13F Managers

Manager	Shares	Value
Ninety One Uk Ltd	2.1M	$310M
Assenagon Asset Management S.A.	964,903	$140M
Davenport & Co Llc	256,201	$37M
Ninety One North America, Inc.	155,719	$23M
Schaper Benz & Wise Investment Cou	59,985	$9M
Wealth Enhancement Advisory Servic	32,021	$4M

EDGAR 13F holdings as of 2026-09-30; filer values normalized to dollars.

2.9 · Top ETF & Fund Ownership

Fund	Weight	Position
FCNTX	0.2%	$399M
FCNKX	0.2%	$399M
VITSX	0.0%	$310M
VTSAX	0.0%	$310M
VSMPX	0.0%	$310M
VTI	0.0%	$310M

13F Filers Holding ALGN — quarterly

Institutional Put/Call — quarterly

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Daily short-sale volume as % of volume reported in FINRA's short-sale file — a flow measure, not short interest; dashed = 50-day average.

Latest Session66.5%2026-10-15

20-Day Avg64.2%50-day 63.4%

TrendRising20d vs 50d

By Market CenterQ: 66% · N: 90% · B: 88%latest session

Weekly Notional ($B)

Where ALGN Trades in the Dark

ATS Venue (4-wk)	Shares	Avg trade
Incr Intelligent Cross Llc	1.3M	32 sh
Ubsa Ubs Ats	1.1M	39 sh
Sgmt Sigma X2	0.9M	33 sh
Mlix Instinct X	0.8M	50 sh
Mstx Ms Trajectory Cross (Ats-1)	0.7M	22 sh
Ebxl Level Ats	0.6M	22 sh

Where a dollar of Align Technology, Inc. revenue goes. All values FY2025 filings, live.

Region	Revenue	Share
UNITED STATES	$1.7B	41%
Other International	$1.5B	36%
SWITZERLAND	$921M	23%

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

ALGN (live moat model)Peer median: GMED · PODD · GKOS · BIO · MASI

Component scores from the live moat model. Peer median illustrative.

Moat score 54/100 — Weak; primary source Cost Advantage.

3.8 · Employees (SEC filings)

Officer	Title
Joseph Hogan	President, Chief Executive Officer & Director
Zelko Relic	Executive Vice President & Chief Technology Officer
John F. Morici	Chief Financial Officer & Executive Vice President of Global Finance
Richardson Jaime Holte	Executive Vice President of Global Human Resources

Revenue ($B)

EPS ($) — GAAP diluted actual, street-basis estimate

Actual bars are GAAP diluted EPS from the filed income statement; the lighter forward bars are street-basis consensus. The two are different measures and are not comparable quarter to quarter.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Quarterly EPS — Actual vs. Consensus

Beats (>2%)4 of 6recent quarters

Avg Surprise+6.2%

Next Report2026-10-28

Income Quality3.93OCF ÷ net income

Beat Rate—%0 of 0 quarters

Current Streak0longest 0

Avg EPS Surprise—%median —%

Surprise Trend—last 4 vs prior 4

Period	EPS est.	EPS actual	EPS surprise	Rev est. ($M)	Rev actual ($M)	Rev surprise

Announcement dates to . Consensus as it stood at each report. Revenue surprise shown where both estimate and actual are filed. A beat record is history, not a forecast.

Profit Margins (%)

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Revenue by Segment — Stacked

Live segmentation data.

YoY Growth Heatmap — Income Lines

YoY growth	FY21	FY22	FY23	FY24	FY25
Revenue	+59.9%	-5.5%	+3.4%	+3.5%	+0.9%
Gross profit	+66.5%	-10.3%	+2.8%	+3.4%	-1.5%
Operating income	+152.2%	-34.2%	+0.1%	-5.6%	+1.4%
Net income	-56.5%	-53.2%	+23.1%	-5.3%	-2.6%

$B · FY ends	FY21	FY22	FY23	FY24	FY25
Revenue	4.0	3.7	3.9	4.0	4.0
Cost of revenue	1.0	1.1	1.2	1.2	1.3
Gross profit	2.9	2.6	2.7	2.8	2.8
R&D expense	0.3	0.3	0.3	0.4	0.4
SG&A expense	1.7	1.7	1.7	1.8	1.8
Operating income	1.0	0.6	0.6	0.6	0.6
EBITDA	1.1	0.8	0.8	0.8	0.8
D&A	0.1	0.1	0.1	0.1	0.2
Pretax income	1.0	0.6	0.6	0.6	0.6
Income tax	0.2	0.2	0.2	0.2	0.2
Net income	0.8	0.4	0.4	0.4	0.4
Diluted EPS ($)	9.69	4.61	5.81	5.62	5.65
Diluted shares (M)	80	78	77	75	73

Operating CF$1B

CapEx$0B

Free cash flow$0B

SBC$0B

Buybacks$0B

Net cash change$0B

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Balance Sheet — Full

$B	FY22	FY23	FY24	FY25
Cash & equivalents	0.9	0.9	1.0	1.1
ST investments	0.1	0.0	0.0	0.0
Receivables (net)	1.0	1.0	1.0	1.2
Total current assets	2.4	2.4	2.5	2.6
PP&E (net)	1.4	1.4	1.4	1.2
Goodwill + intangibles	0.5	0.5	0.5	0.6
Total assets	5.9	6.1	6.2	6.2
Accounts payable	0.1	0.1	0.1	0.1
Short-term debt	0.0	0.0	0.0	0.0
Deferred revenue	1.3	1.4	1.3	1.3
Total current liabilities	1.9	2.1	2.0	1.9
Long-term debt	0.0	0.0	0.0	0.0
Total liabilities	2.3	2.5	2.4	2.2
Shareholders' equity	3.6	3.6	3.9	4.0

Cash Flow Statement — Full

$B	FY22	FY23	FY24	FY25
Net income	0.4	0.4	0.4	0.4
D&A	0.1	0.1	0.1	0.2
Stock-based compensation	0.1	0.2	0.2	0.0
Working capital change	(0.1)	(0.0)	(0.1)	(0.4)
Operating cash flow	0.6	0.8	0.7	0.6
Capital expenditures	(0.3)	(0.2)	(0.1)	(0.1)
Investing cash flow	(0.2)	(0.2)	(0.3)	(0.1)
Buybacks	(0.4)	(0.6)	(0.4)	(0.5)
Dividends paid	0.0	0.0	0.0	0.0
Debt issuance / (repay)	0.0	0.0	0.0	0.0
Financing cash flow	(0.5)	(0.6)	(0.4)	(0.5)
Free cash flow	0.3	0.6	0.6	0.5

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Balance Sheet Structure ($B)

Cash Generation vs Capex ($B)

Left: what the balance sheet is made of — the gap between the assets bar and the liabilities bar is book equity. Right: whether the capex bar is covered by the operating-cash bar; where it is not, the difference was funded externally and free cash flow goes negative.

Ratio	FY21	FY22	FY23	FY24	FY25	TTM
PROFITABILITY
ROE	22.5%	10.0%	12.3%	11.3%	10.4%	10%
ROA	14.3%	6.1%	7.4%	6.9%	6.6%	6.4%
ROIC	28.9%	14.2%	16.0%	14.4%	12.6%	8.8%
Gross margin	74.3%	70.5%	70.1%	70.0%	68.3%	66.5%
Operating margin	24.7%	17.2%	16.7%	15.2%	15.3%	13.3%
Net margin	19.5%	9.7%	11.5%	10.5%	10.2%	10.0%
EBITDA margin	27.5%	20.9%	20.7%	20.4%	19.0%	19.0%
FCF margin	19.5%	7.4%	15.7%	15.6%	14.7%	—
VALUATION
P/E	67.62	45.31	46.67	36.85	27.31	25.6
P/B	14.41	4.55	5.72	4.03	2.77	2.5
P/S	13.21	4.39	5.38	3.88	2.78	2.53
P/FCF	67.67	59.18	34.16	24.94	18.89	13.8
EV/EBITDA	47.14	19.89	24.93	17.88	12.64	12.1
EV/Revenue	12.94	4.15	5.16	3.65	2.53	2.3
Earnings yield	1.5%	2.2%	2.1%	2.7%	3.7%	3.93%
FCF yield	1.5%	1.7%	2.9%	4.0%	5.3%	7.22%

Ratio	FY21	FY22	FY23	FY24	FY25	TTM
LEVERAGE & SOLVENCY
Current ratio	1.30	1.26	1.18	1.22	1.36	1.40
Quick ratio	1.18	1.08	1.04	1.10	1.24	1.28
Debt / equity	0.03	0.04	0.03	0.03	0.03	0.03
Debt / assets	2.1%	2.1%	2.1%	1.9%	1.8%	1.9%
Net debt / EBITDA	-0.96	-1.12	-1.06	-1.13	-1.21	-1.25
Interest coverage	—	—	—	—	365.22	—

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Ratio	FY21	FY22	FY23	FY24	FY25	TTM
EFFICIENCY
Asset turnover	0.73	0.63	0.64	0.65	0.65	0.65
Receivables turnover	5.08	4.25	4.38	4.21	3.85	3.6
DSO (days)	72	86	83	87	95	101
DPO (days)	55	48	38	34	32	29
Cash conversion cycle	83	132	146	137	130	128
GROWTH (YoY)
Revenue growth	59.9%	-5.5%	3.4%	3.5%	0.9%	—
Net income growth	-56.5%	-53.2%	23.1%	-5.3%	-2.6%	—
EPS growth	-56.5%	-52.1%	26.1%	-3.6%	1.1%	—
FCF growth	52.1%	-64.1%	119.6%	2.4%	-4.7%	—
PER SHARE ($)
EPS (diluted, TTM)	9.72	4.65	5.87	5.66	5.72	5.79
Book value / share	45.61	46.36	47.89	51.73	56.43	59.23
Revenue / share	49.76	48.08	50.95	53.70	56.23	57.93
FCF / share	9.71	3.56	8.02	8.36	8.27	10.58
Cash / share	14.75	12.87	12.83	14.02	15.26	15.43
SHAREHOLDER RETURN & SCORES
Buyback yield	0.7%	2.7%	2.9%	2.3%	3.5%	0.77%
Altman Z-Score	15.44	5.88	6.71	5.59	4.71	4.5
Piotroski F-Score	5	4	8	8	7	7/9
Beneish M-Score	-2.39	-2.60	-2.69	-2.72	-2.46	-2.65

Model	Score	Zone	Note
Piotroski F-Score	7 / 9	Strong
Altman Z-Score	4.5	Safe (>2.99)	Safe
Income quality	3.93	Cash-backed	OCF ÷ net income
Beneish M-Score	-2.65	Non-manipulator	vs −2.22 threshold

DuPont Decomposition (TTM)	Value
Tax burden	0.73
Interest burden	1.00
Operating margin	13.7%
Asset turnover	0.66×
Financial leverage	1.55×
= ROE	10%

Growth Quality (live)	Value
Revenue stability	0.98
Earnings stability	0.47
Earnings persistence	0.98
Revenue CAGR 3y	3.5%
EPS CAGR 3y	12.1%
FCF CAGR 3y	7.3%

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Buyback Yield0.77%

Dividend Yield0.00%none paid

Total Shareholder Return0.71%cash yield

SBC / Revenue4.5%dilution pressure

Company	Mkt cap	P/E	ROE	Net margin	Rev growth	Piotroski	1-yr ret
GMED	$10.3B	19.3	12%	19.2%	+19.7%	8/9	+30.9%
PODD	$9.8B	26.3	26%	11.8%	+29.4%	9/9	-55.4%
GKOS	$9.7B	-50.7	-26%	-9.9%	+41.5%	3/9	+93.2%
BIO	$9.5B	42.5	3%	57.1%	+1.4%	7/9	+13.2%
MASI	$9.4B	125.0	9%	14.1%	-14.4%	7/9	—
SNN	$12.2B	19.0	22%	9.8%	+11.5%	8/9	—
PEN	$12.6B	78.4	11%	8.9%	+17.6%	6/9	—
BRKR	$8.3B	-78.4	-3%	-6.2%	+1.6%	6/9	—

1-yr returns computed from adjusted price history; peers without a tracked series show —.

Buy

33 Analysts

Str Sell (0)Sell (2)Hold (9)Buy (22)Str Buy (0)

Mean Target (qtr)$185.254 targets

Target vs. Price+25.8%last-quarter mean

Next Report2026-10-28street $2.78

Consensus estimates	Revenue mean	High / Low	EPS mean	High / Low	# EPS est.
FY2026	$4.15B	$4.17B / $4.11B	$11.26	$11.66 / $10.96	10
FY2027	$4.30B	$4.40B / $4.17B	$12.41	$12.80 / $11.67	10
FY2028	$4.50B	$4.73B / $4.22B	$13.54	$15.13 / $12.34	5

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Street Price Target — Trajectory

Window	Avg Target	vs. Price	# Targets
Last Month	$184.00	+24.9%	3
Last Quarter	$185.25	+25.8%	4
Last Year	$196.95	+33.7%	21
All Time	$289.31	+96.4%	51

Rolling mean of published targets vs. last close $147.31. Aggregated from StreetInsider, Benzinga, Pulse 2.0.

Third-Party Composite Rating

A-

DCF

4/5

ROE

3/5

ROA

5/5

Debt/Eq

4/5

P/E

2/5

P/B

2/5

Independent quant composite as of 2026-10-16; components scored 1–5 (5 best). Shown for contrast with the InsiderStreet Score — methodologies differ.

ALGN +13.5% vs S&P 500 +15.9% — spread -2.4pp

Sector — XLV +24.2%

Peer Set — indexed to 100

All series indexed to 100 at the start of the window, adjusted closes.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Candlesticks with SMA 20/50 overlay, Bollinger (20,2σ) band, volume, and Wilder RSI(14) — computed from live daily OHLCV.

Moving Average	Value	Distance	% Distance	Signal
SMA 20	$144.75	+2.56	+1.77%	Above
SMA 50	$154.31	-7.00	-4.54%	Below
SMA 200	$169.51	-22.20	-13.10%	Below
EMA 9	$144.86	+2.45	+1.69%	Above
EMA 21	$146.08	+1.23	+0.84%	Above
EMA 50	$152.72	-5.41	-3.54%	Below
EMA 200	$164.39	-17.08	-10.39%	Below

Series and readings from the nightly technical-indicator history — identical data to the site's ribbon chart. Supertrend segments colored by direction.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

TECHNICAL VERDICTLEAN BULLISHPower Score +1014 of 22 indicator votes bullish

Family Scores (site weights)

Trend 30%33

Momentum 25%73

Volume 20%81

Volatility 10%33

Patterns 15%50

This Week55% bullishof 11 price-based votes

4 Weeks Ago0%+55 pts since

12 Weeks Ago27%+28 pts since

ReadImprovingweek-over-week trajectory

Price vs SMA 20$144.75

Price vs SMA 50$154.31

Price vs SMA 200$169.51

EMA 9/21 Cross144.9/146.1

SMA 50/200Death

ADX DirectionADX 25

Supertrend$152

Parabolic SAR$139

SMA Slope-0.020

RSI49.8

Stochastic K/D75/62

StochRSI K/D94/92

Williams %R-34

CCI103

TSI vs Signal-15.6

CMO-0.4

ROC2.48%

OBV SignalAccum

Chaikin MF0.130

MFI61

Force Index0M

Elder Ray Bull6.01

RSI (14)30 oversold · 70 overbought

Stochastic %Kvs %D 62

Money Flowvolume-weighted RSI

ADXtrend strength · <20 weak

Williams %Rinverted scale

Level	Value	Level	Value
Pivot / R1 / R2	$147.19 / $151.93 / $154.52	S1 / S2	$144.60 / $139.86
Bollinger (20,2)	$138.21 – $151.29	Squeeze	Off
52-wk range	$128.65 – $200.44	Off 52-wk high	-26.5%
ATR (14)	$4.38 (3.0%)	Historical vol	29.9%

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

+1.9%Jan55%

+0.5%Feb55%

+0.6%Mar52%

+8.0%Apr60%

+0.6%May45%

+0.5%Jun65%

+1.0%Jul55%

-0.2%Aug55%

+3.5%Sep60%

+1.0%Oct50%

+3.8%Nov75%

+3.6%Dec75%

Sample: 20 years — treat short histories as suggestive, not statistical.

Computed from live weekly prices	ALGN	S&P 500
Weekly volatility (σ, 1y)	5.42%	1.83%
Best / worst week (1y)	+22.4% / -7.2%	—
Max drawdown (5y, monthly)	-82.4%	—
1-week VaR (95%)	-6.5%	—
Beta (5y)	1.64	1.00

ALGN EQUITY WEATHER (LIVE)RAINY · -26

Trend-43

Momentum+22

Volume-33

Volatility-60

Breadth-30

MARKET REGIME (2026-10-16)NEUTRAL

VIX19.99Normal

Dow TheoryConfirmed Bearish

SPY / QQQ TSI7.2 / 4.7trend strength

Sector Strength46/100breadth average

Average sentiment of 182 stories, weekly buckets, −1 to +1.

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Overall-25.8-5.6 vs industry

Trend-42.8-20.7 vs industry

Momentum+22.3+44.4 vs industry

Volume-32.8-27.8 vs industry

Reading	ALGN	Medical - Devices n=524	Healthcare n=5,272	All US symbols n=70,435
Overall	-25.8	-20.2	-24.0	-20.5
Trend	-42.8	-22.1	-25.6	-21.3
Momentum	+22.3	-22.0	-28.5	-15.8
Volume	-32.8	-5.0	-25.0	-3.8

Trend, momentum and volume are computed per company. Volatility and breadth are market-regime values shared by every symbol in the universe, so they are reported once under Market Regime rather than compared here - a company cannot differ from its sector on a constant.

Executive	Total comp	Structure
Joseph M. Hogan, President and Chief Execut	$19.2M	93% equity+incentive
John F. Morici, Chief Financial Officer and	$5.7M	87% equity+incentive
Julie Coletti, Executive Vice President, Chi	$4.5M	85% equity+incentive
Stuart Hockridge, Executive Vice President,	$2.8M	80% equity+incentive

Pillar (live disclosure scores)	Score
Environmental	62
Social	58
Governance	60
Composite ESG	60

Composite ESG Trend

Filed	8-K contents	Items
2026-08-31	Officer/Director Change; Exhibits	5.02,9.01
2026-07-29	Earnings Release; Exhibits	2.02,9.01
2026-07-29	Regulation FD; Exhibits	7.01,9.01
2026-07-09	Officer/Director Change	5.02
2026-06-22	Officer/Director Change; Regulation FD; Exhibits	5.02,7.01,9.01
2026-05-20	Shareholder Vote; Exhibits	5.07,9.01
2026-05-01	Regulation FD; Exhibits	7.01,9.01
2026-04-29	Earnings Release; Exhibits	2.02,9.01

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Methodology. Every figure originates in InsiderStreet's production data layer and is computed deterministically by the same engines that power insiderstreet.ai. This factsheet contains no model-written text. Sections without underlying data are omitted rather than estimated.

DISCLOSURES. This document is produced by InsiderStreet.ai from live production data. It is not investment advice, not an offer or solicitation to buy or sell any security, and not a recommendation tailored to any person. Data is sourced as of the dates shown and may no longer be current. InsiderStreet.ai is not a registered investment adviser or broker-dealer. Investing involves risk, including loss of principal. Past performance does not guarantee future results. Do not make any investment decision based on this document. © 2026 InsiderStreet.ai — all rights reserved. Redistribution prohibited.

Data domain	Source	Coverage for this report
Price & volume	market_db.historical_prices	52 rows
Fundamentals	income_statements_annual	6 rows · 2020 to 2025
Reported vs consensus	fact/earnings_calendar	24 rows · 2020-10-21 to 2026-07-29
Analyst estimates	dim/forward_estimates	3 rows · 2026-12-31 to 2028-12-31
Institutional ownership (13F)	holdings_db.institutional_ownership_summary	102 rows · 2001 to 2026
Insider transactions (Form 4)	edgar/form4	12 rows · 2026-05-20 to 2026-08-27
Proposed sales (Form 144)	edgar/form144	1 record
Beneficial ownership (13D/G)	edgar/13dg	4 rows · 2026-05-14 to 2026-08-12
Short-sale volume (FINRA)	edgar/short_volume_daily	60 rows · 2026-07-23 to 2026-10-15
Dark pool (ATS, tier 1)	edgar/darkpool_weekly	12 rows · 2026-06-15 to 2026-08-31
ETF & fund holding	etf_holdings_changelog (30d)	1 record
Peer set	stock_peers_dynamic	8 rows
Industry medians	industry_medians	1 record
Congressional trades	congress_db (House + Senate)	1 record
ESG	fact/esg_disclosures	1 record

Method. Every figure in this factsheet is looked up from a named field computed in code. It contains no model-written text.

Not covered. Short interest as a percent of float and days-to-cover are not in this data set — the short-sale figures above are FINRA volume, a flow, and cannot support squeeze or covering analysis. Options positioning and intraday data are also absent. 13F ownership is filed 45 days after quarter end and congressional trades are disclosed on a lag, so both describe a past position, not a current one.

Align Technology, Inc. (ALGN)

Align Technology, Inc. (ALGN)

Score Breakdown

Peer Comparison — IS Score

IS Score Trend — quarterly

Align Technology, Inc. (ALGN)

Institutions holding — 12 quarters

Align Technology, Inc. (ALGN)

Monthly Net Insider Flow (000 shares)

Signal Summary

Align Technology, Inc. (ALGN)

2.8 · Largest Reporting 13F Managers

2.9 · Top ETF & Fund Ownership

13F Filers Holding ALGN — quarterly

Institutional Put/Call — quarterly

Align Technology, Inc. (ALGN)

Where ALGN Trades in the Dark

Align Technology, Inc. (ALGN)

3.8 · Employees (SEC filings)

Align Technology, Inc. (ALGN)

Align Technology, Inc. (ALGN)

Align Technology, Inc. (ALGN)

Balance Sheet — Full

Cash Flow Statement — Full

Align Technology, Inc. (ALGN)

Align Technology, Inc. (ALGN)

Align Technology, Inc. (ALGN)

Align Technology, Inc. (ALGN)

Street Price Target — Trajectory

Third-Party Composite Rating

Align Technology, Inc. (ALGN)

Align Technology, Inc. (ALGN)

Family Scores (site weights)

Align Technology, Inc. (ALGN)

Align Technology, Inc. (ALGN)

Align Technology, Inc. (ALGN)